{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:27:57Z","timestamp":1786609677788,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"DOI":"10.7759\/cureus.114453","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:36:50Z","timestamp":1786606610000},"source":"Crossref","is-referenced-by-count":0,"title":["Periaortitis and Retroperitoneal Fibrosis in a Patient With a Normal IgG4 Level: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Khaled Mohamed S","family":"Alarbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Almubarak S","family":"Elkhidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roba  K","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Nishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Niraula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaseem","family":"Sirajudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishan K","family":"Purayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamanjore A","family":"Naushad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio A","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006, 367:241-51. 10.1016\/S0140-6736(06)68035-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16100-X","article-title":"Asbestos exposure as a risk factor for retroperitoneal fibrosis","volume":"363","author":"Uibu T","year":"2004","unstructured":"Uibu T, Oksa P, Auvinen A, et al.. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004, 363:1422-6. 10.1016\/S0140-6736(04)16100-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel EF","year":"2009","unstructured":"van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009, 88:193-201. 10.1097\/MD.0b013e3181afc420","journal-title":"Medicine (Baltimore)"},{"key":"ref4","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"Koep L","year":"1977","unstructured":"Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery. 1977, 81:250-7.","journal-title":"Surgery"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199702000-00003","article-title":"Inflammatory aortic aneurysms. A clinical review with new perspectives in pathogenesis","volume":"225","author":"Rasmussen TE","year":"1997","unstructured":"Rasmussen TE, Hallett JW Jr. Inflammatory aortic aneurysms. A clinical review with new perspectives in pathogenesis. Ann Surg. 1997, 225:155-64. 10.1097\/00000658-199702000-00003","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2020.104018","article-title":"Aortitis and periaortitis: the puzzling spectrum of inflammatory aortic diseases","volume":"49","author":"Marvisi C","year":"2020","unstructured":"Marvisi C, Accorsi Buttini E, Vaglio A. Aortitis and periaortitis: the puzzling spectrum of inflammatory aortic diseases. Presse Med. 2020, 49:104018. 10.1016\/j.lpm.2020.104018","journal-title":"Presse Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-020-02486-6","article-title":"Etiology, diagnosis and management of aortitis","volume":"43","author":"Sharma S","year":"2020","unstructured":"Sharma S, Pandey NN, Sinha M, Chandrashekhara SH. Etiology, diagnosis and management of aortitis. Cardiovasc Intervent Radiol. 2020, 43:1821-1836. 10.1007\/s00270-020-02486-6","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02197-w","article-title":"IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease","volume":"22","author":"Peng L","year":"2020","unstructured":"Peng L, Zhang P, Li J, et al.. IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther. 2020, 22:103. 10.1186\/s13075-020-02197-w","journal-title":"Arthritis Res Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S239160","article-title":"Renal involvement in retroperitoneal fibrosis: prevalence, impact and management challenges","volume":"14","author":"Mizushima I","year":"2021","unstructured":"Mizushima I, Kawano M. Renal involvement in retroperitoneal fibrosis: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2021, 14:279-89. 10.2147\/IJNRD.S239160","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.3629","article-title":"Retroperitoneal fibrosis: a review of clinical features and imaging findings","volume":"191","author":"Cronin CG","year":"2008","unstructured":"Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. 2008, 191:423-31. 10.2214\/AJR.07.3629","journal-title":"AJR Am J Roentgenol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial","volume":"378","author":"Vaglio A","year":"2011","unstructured":"Vaglio A, Palmisano A, Alberici F, et al.. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011, 378:338-46. 10.1016\/S0140-6736(11)60934-3","journal-title":"Lancet"},{"key":"ref12","article-title":"Retroperitoneal fibrosis","volume":"60","author":"van Bommel EF","year":"2002","unstructured":"van Bommel EF. Retroperitoneal fibrosis. Neth J Med. 2002, 60:231-42.","journal-title":"Neth J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000521423","article-title":"Retroperitoneal fibrosis is still an underdiagnosed entity with poor prognosis","volume":"47","author":"\u0141o\u0144 I","year":"2022","unstructured":"\u0141o\u0144 I, Wieliczko M, Lewandowski J, Ma\u0142yszko J. Retroperitoneal fibrosis is still an underdiagnosed entity with poor prognosis. Kidney Blood Press Res. 2022, 47:151-62. 10.1159\/000521423","journal-title":"Kidney Blood Press Res"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00966-9","article-title":"Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis","volume":"23","author":"Fenaroli P","year":"2021","unstructured":"Fenaroli P, Maritati F, Vaglio A. Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis. Curr Rheumatol Rep. 2021, 23:18.","journal-title":"Curr Rheumatol Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14218","article-title":"Current approach to diagnosis and management of retroperitoneal fibrosis","volume":"27","author":"Tanaka T","year":"2020","unstructured":"Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol. 2020, 27:387-94. 10.1111\/iju.14218","journal-title":"Int J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01968-8","article-title":"Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review","volume":"22","author":"Si M","year":"2022","unstructured":"Si M, Zhang K, Li J, He H, Yao Y, Han J, Qiao J. Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review. BMC Womens Health. 2022, 22:399. 10.1186\/s12905-022-01968-8","journal-title":"BMC Womens Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17587","article-title":"Retroperitoneal fibrosis: beware of lymphoma","volume":"13","author":"Ouchani M","year":"2021","unstructured":"Ouchani M, Bachir H, Hamaz S, Alaoui H, Serraj K. Retroperitoneal fibrosis: beware of lymphoma. Cureus. 2021, 13:e17587. 10.7759\/cureus.17587","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.946675","article-title":"Management of retroperitoneal fibrosis with endovascular aneurysm repair in patients refractory to medical management","volume":"9","author":"Sultan S","year":"2022","unstructured":"Sultan S, Acharya Y, Hezima M, et al.. Management of retroperitoneal fibrosis with endovascular aneurysm repair in patients refractory to medical management. Front Surg. 2022, 9:946675. 10.3389\/fsurg.2022.946675","journal-title":"Front Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-67175-4_16","article-title":"Isolated aortitis and periaortitis","author":"Marvisi C","year":"2021","unstructured":"Marvisi C, Fortunato L, Vaglio A. Isolated aortitis and periaortitis. Large and Medium Size Vessel and Single Organ Vasculitis. Rare Diseases of the Immune System. Salvarani C, Boiardi L, Muratore F (ed): Springer, Cham, Switzerland; 2021. 10.1007\/978-3-030-67175-4_16"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2020-318041","article-title":"The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations","volume":"107","author":"Shakir A","year":"2021","unstructured":"Shakir A, Wheeler Y, Krishnaswamy G. The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations. Heart. 2021, 107:790-798.","journal-title":"Heart"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100074","article-title":"IgG4-related disease: changing epidemiology and new thoughts on a multisystem disease","volume":"4","author":"Floreani A","year":"2021","unstructured":"Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun. 2021, 4:100074. 10.1016\/j.jtauto.2020.100074","journal-title":"J Transl Autoimmun"},{"key":"ref22","article-title":"Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis","volume":"54","author":"Kharagjitsing HHS","year":"2022","unstructured":"Kharagjitsing HHS, Hendriksz TR, Fouraux MA, van Gelder T, van Bommel EF. Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis. Int Urol Nephrol. 2022, 54:2663-2671.","journal-title":"Int Urol Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.371","article-title":"A review of the current treatment methods for retroperitoneal fibrosis with obstructive uropathy","volume":"5","author":"Carey C","year":"2024","unstructured":"Carey C, Gurumurthy G, Napier-Hemy R, Zelhof B. A review of the current treatment methods for retroperitoneal fibrosis with obstructive uropathy. BJUI Compass. 2024, 5:835-845. 10.1002\/bco2.371","journal-title":"BJUI Compass"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-99934-2.00026-7","article-title":"Expertise area 2.4: rare retroperitoneal diseases and conditions","author":"Amesty MV","year":"2024","unstructured":"Amesty MV, Rivas S, Dal Moro F, Mancini M. Expertise area 2.4: rare retroperitoneal diseases and conditions. Rare and Complex Urology. Feitz WF, Tidman J (ed): Academic Press, New York, NY; 2024. 10.1016\/B978-0-323-99934-2.00026-7"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5606\/tgkdc.dergisi.2022.22228","article-title":"Incidentally detected aortitis during coronary bypass surgery: a case report","volume":"30","author":"Bu\u011fra AK","year":"2022","unstructured":"Bu\u011fra AK, Bu\u011fra A, Kadiro\u011fullar\u0131 E, Onan B. Incidentally detected aortitis during coronary bypass surgery: a case report. Turk Gogus Kalp Damar Cerrahisi Derg. 2022, 30:267-71. 10.5606\/tgkdc.dergisi.2022.22228","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2010.09.003","article-title":"Isolated thoracic aortitis: clinicopathological and immunohistochemical study of 11 cases","volume":"20","author":"Laco J","year":"2011","unstructured":"Laco J, Steiner I, Holubec T, Dominik J, Holubcova Z, Vojacek J. Isolated thoracic aortitis: clinicopathological and immunohistochemical study of 11 cases. Cardiovasc Pathol. 2011, 20:352-60. 10.1016\/j.carpath.2010.09.003","journal-title":"Cardiovasc Pathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.06.031","article-title":"Long-term outcome and prognosis of noninfectious thoracic aortitis","volume":"82","author":"Espitia O","year":"2023","unstructured":"Espitia O, Bruneval P, Assaraf M, et al.. Long-term outcome and prognosis of noninfectious thoracic aortitis. J Am Coll Cardiol. 2023, 82:1053-64. 10.1016\/j.jacc.2023.06.031","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2022.2145744","article-title":"IgG4 related disease and aortitis: an up-to-date review","volume":"52","author":"Jayachamarajapura Onkaramurthy N","year":"2023","unstructured":"Jayachamarajapura Onkaramurthy N, Suresh SC, Theetha Kariyanna P, Jayarangaiah A, Prakash G, Raju B. IgG4 related disease and aortitis: an up-to-date review. Scand J Rheumatol. 2023, 52:306-16. 10.1080\/03009742.2022.2145744","journal-title":"Scand J Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6624","article-title":"Medical challenge posed by retroperitoneal fibrosis: case reports and literature review","volume":"12","author":"Cervera-Bonilla S","year":"2020","unstructured":"Cervera-Bonilla S, Garcia Mora M, Rodriguez Ossa P, Messa O, Mendoza D\u00edaz S. Medical challenge posed by retroperitoneal fibrosis: case reports and literature review. Cureus. 2020, 12:e6624. 10.7759\/cureus.6624","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2019.1609152","article-title":"Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature","volume":"75","author":"Roussel E","year":"2020","unstructured":"Roussel E, Callemeyn J, Van Moerkercke W. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature. Acta Clin Belg. 2020, 75:239-44. 10.1080\/17843286.2019.1609152","journal-title":"Acta Clin Belg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02627-3","article-title":"Association of retroperitoneal fibrosis with malignancy and its outcomes","volume":"23","author":"Lee SJ","year":"2021","unstructured":"Lee SJ, Eun JS, Kim MJ, Song YW, Kang YM. Association of retroperitoneal fibrosis with malignancy and its outcomes. Arthritis Res Ther. 2021, 23:249. 10.1186\/s13075-021-02627-3","journal-title":"Arthritis Res Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-021-00445-w","article-title":"State of the art of (18)F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation","volume":"9","author":"Casali M","year":"2021","unstructured":"Casali M, Lauri C, Altini C, et al.. State of the art of (18)F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging. 2021, 9:299-339. 10.1007\/s40336-021-00445-w","journal-title":"Clin Transl Imaging"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.08.108","article-title":"The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms","volume":"160","author":"Leone O","year":"2020","unstructured":"Leone O, Corsini A, Pacini D, et al.. The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2020, 160:1434-1443. 10.1016\/j.jtcvs.2019.08.108","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2021.03.002","article-title":"Including medical management in the urologic approach to idiopathic retroperitoneal fibrosis","volume":"152","author":"Santiago J","year":"2021","unstructured":"Santiago J, Swartz R, Marder W, Daignault-Newton S, Malaeb B, Wolf JS Jr, Ambani S. Including medical management in the urologic approach to idiopathic retroperitoneal fibrosis. Urology. 2021, 152:167-172.","journal-title":"Urology"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1159\/000526114","article-title":"Idiopathic retroperitoneal fibrosis: what is the optimal clinical approach for long-term preservation of renal function?","volume":"107","author":"Giannese D","year":"2023","unstructured":"Giannese D, Moriconi D, Cupisti A, et al.. Idiopathic retroperitoneal fibrosis: what is the optimal clinical approach for long-term preservation of renal function?. Urol Int. 2023, 107:134-147.","journal-title":"Urol Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17940","article-title":"An interesting case of immunoglobulin G4-related retroperitoneal fibrosis treated with rituximab","volume":"13","author":"Hamdan A","year":"2021","unstructured":"Hamdan A, Moeen Z, Tariq H, Olson O, Matute-Martinez C, Sidhu M, Mukkera S. An interesting case of immunoglobulin G4-related retroperitoneal fibrosis treated with rituximab. Cureus. 2021, 13:e17940. 10.7759\/cureus.17940","journal-title":"Cureus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/03915603241270453","article-title":"Exploring retroperitoneal fibrosis: Insights, challenges, and treatment approaches","volume":"92","author":"Mehedra A","year":"2025","unstructured":"Mehedra A, Maachi Y, Babty M, et al.. Exploring retroperitoneal fibrosis: Insights, challenges, and treatment approaches. Urologia. 2025, 92:14-20. 10.1177\/03915603241270453","journal-title":"Urologia"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09163-3","article-title":"Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement","volume":"68","author":"Quattrocchio G","year":"2020","unstructured":"Quattrocchio G, Barreca A, Demarchi A, et al.. Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement. Immunol Res. 2020, 68:340-52. 10.1007\/s12026-020-09163-3","journal-title":"Immunol Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620934911","article-title":"European guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr JM","year":"2020","unstructured":"L\u00f6hr JM, Beuers U, Vujasinovic M, et al.. European guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020, 8:637-66. 10.1177\/2050640620934911","journal-title":"United European Gastroenterol J"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcaa327","article-title":"An international patient-centred study of retroperitoneal fibrosis","volume":"115","author":"Dattani R","year":"2022","unstructured":"Dattani R, Barwick TD, El Wardany G, et al.. An international patient-centred study of retroperitoneal fibrosis. QJM. 2022, 115:148-154.","journal-title":"QJM"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1259\/bjrcr.20190086","article-title":"Retroperitoneal fibrosis-the long and winding path","volume":"6","author":"Suwathep P","year":"2020","unstructured":"Suwathep P, Khan A, Husein R, Huasen B, Bose P, Brady M. Retroperitoneal fibrosis-the long and winding path. BJR Case Rep. 2020, 6:20190086. 10.1259\/bjrcr.20190086","journal-title":"BJR Case Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020132","article-title":"Immunosuppressive treatment in antiphospholipid syndrome: is it worth it?","volume":"9","author":"Mormile I","year":"2021","unstructured":"Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive treatment in antiphospholipid syndrome: is it worth it?. Biomedicines. 2021, 9:132. 10.3390\/biomedicines9020132","journal-title":"Biomedicines"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02786","article-title":"Erratum: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline Update","volume":"40","author":"Schneider BJ","year":"2022","unstructured":"Schneider BJ, Naidoo J, Santomasso BD, et al.. Erratum: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline Update. J Clin Oncol. 2022, 40:315. 10.1200\/JCO.21.02786","journal-title":"J Clin Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.36347\/sasjm.2023.v09i04.027","article-title":"A rare case of retroperitoneal fibrosis extending into the peritoneum: case report","volume":"4","author":"Dahman H","year":"2023","unstructured":"Dahman H, Azzahiri I, Hammoune N, Mouhsine A, Atmane E. A rare case of retroperitoneal fibrosis extending into the peritoneum: case report. SAS J Med. 2023, 4:352-5. 10.36347\/sasjm.2023.v09i04.027","journal-title":"SAS J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-021-00375-y","article-title":"Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature","volume":"16","author":"Coccolini F","year":"2021","unstructured":"Coccolini F, Improta M, Cicuttin E, et al.. Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature. World J Emerg Surg. 2021, 16:33. 10.1186\/s13017-021-00375-y","journal-title":"World J Emerg Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/481279-periaortitis-and-retroperitoneal-fibrosis-in-a-patient-with-a-normal-igg4-level-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:36:53Z","timestamp":1786606613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/481279-periaortitis-and-retroperitoneal-fibrosis-in-a-patient-with-a-normal-igg4-level-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.114453","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}